Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Author
CADTH Canadian Drug Expert Committee
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Showing
21
-
40
of
214
Search:
'CADTH Canadian Drug Expert Committee'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
21
CADTH Canadian Drug Expert Committee recommendation: Esketamine (Spravato -- Janssen inc.) : indication: for the treatment of major depressive disorder in adults
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
22
CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
23
CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
24
CADTH Canadian Drug Expert Committee recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) : indication: in adults, as an adjunct to standard of care therapy, for the...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
25
CADTH Canadian Drug Expert Committee recommendation: Nintedanib (Ofev -- Boehringer Ingelheim Canada Inc.) : indication: chronic fibrosing interstitial lung diseases
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
26
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
27
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
28
CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
29
CADTH Canadian Drug Expert Committee recommendation: Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC) : indication : for the treatment of adult patients with cardiomyopathy due t...
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
30
CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
31
CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients 1 yea...
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
32
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
33
CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
34
CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
35
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
36
CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
37
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
38
CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
39
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
40
CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
1
2
3
4
5
6
7
8
9
10
11
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Author/Home?page=2&author=%22CADTH+Canadian+Drug+Expert+Committee%22&type=Author
Send by Email
×
Loading...